COX-2 inhibitory treatment in chronic lymphocytic leukemia: a preliminary clinical study (Q45053453)

9 December 2017

COX-2 inhibitory treatment in chronic lymphocytic leukemia: a preliminary clinical study (English)

1 reference

chronic lymphocytic leukemia

9 December 2017

1 reference

Ismail Oguz Kara

1

1 reference

PubMed ID

15359658

9 December 2017

Berksoy Sahin

series ordinal

2

1 reference

9 December 2017

1 July 2004

1 reference

9 December 2017

1 reference

9 December 2017

45

1 reference

9 December 2017

7

1 reference

9 December 2017

1495-1496

1 reference

Antigen-driven selection of virgin and memory B cells

9 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Caspase activation: the induced-proximity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

Chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001663608

10.1080/10428190410001663608

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15359658